These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36225197)

  • 1. Application of Cytochrome C-Related Genes in Prognosis and Treatment Prediction of Lung Adenocarcinoma.
    Tang M; Li G; Chen L; Tu J
    Dis Markers; 2022; 2022():8809956. PubMed ID: 36225197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of a novel signature incorporating lipid metabolism and immune-related genes for assessing prognosis and immune landscape in lung adenocarcinoma.
    Wang Y; Xu J; Fang Y; Gu J; Zhao F; Tang Y; Xu R; Zhang B; Wu J; Fang Z; Li Y
    Front Immunol; 2022; 13():950001. PubMed ID: 36091041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
    Wu P; Zheng Y; Wang Y; Wang Y; Liang N
    J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Seven-Gene Signature with Close Immune Correlation Was Identified for Survival Prediction of Lung Adenocarcinoma.
    Zou X; Hu Z; Huang C; Chang J
    Med Sci Monit; 2020 Jul; 26():e924269. PubMed ID: 32613949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-related gene signature for predicting LUAD patients' prognosis and immune microenvironment.
    Chen J; Fu Y; Hu J; He J
    Cytokine; 2022 Apr; 152():155820. PubMed ID: 35176657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a Four-Gene Signature Associated with the Prognosis Prediction of Lung Adenocarcinoma Based on Integrated Bioinformatics Analysis.
    Wu Y; Yang L; Zhang L; Zheng X; Xu H; Wang K; Weng X
    Genes (Basel); 2022 Jan; 13(2):. PubMed ID: 35205284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated Analysis of Cell Cycle-Related and Immunity-Related Biomarker Signatures to Improve the Prognosis Prediction of Lung Adenocarcinoma.
    Chen F; Song J; Ye Z; Xu B; Cheng H; Zhang S; Sun X
    Front Oncol; 2021; 11():666826. PubMed ID: 34150632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A ten-gene signature-based risk assessment model predicts the prognosis of lung adenocarcinoma.
    Jiang H; Xu S; Chen C
    BMC Cancer; 2020 Aug; 20(1):782. PubMed ID: 32819300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A New Prognostic Indicator of Immune Microenvironment and Therapeutic Response in Lung Adenocarcinoma Based on Peroxisome-Related Genes.
    Xiong Z; Zhang L; Fan W
    J Immunol Res; 2022; 2022():6084589. PubMed ID: 35935579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of endoplasmic reticulum stress-related eight-gene signature for predicting the overall survival of lung adenocarcinoma.
    Lin L; Zhang W
    Transl Cancer Res; 2022 Jul; 11(7):1909-1924. PubMed ID: 35966313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune landscape and a promising immune prognostic model associated with TP53 in early-stage lung adenocarcinoma.
    Wu C; Rao X; Lin W
    Cancer Med; 2021 Feb; 10(3):806-823. PubMed ID: 33314730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment.
    Zhou H; Zheng M; Shi M; Wang J; Huang Z; Zhang H; Zhou Y; Shi J
    BMC Cancer; 2021 Aug; 21(1):938. PubMed ID: 34416861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment and validation of a prognostic signature for lung adenocarcinoma based on metabolism-related genes.
    Wang Z; Embaye KS; Yang Q; Qin L; Zhang C; Liu L; Zhan X; Zhang F; Wang X; Qin S
    Cancer Cell Int; 2021 Apr; 21(1):219. PubMed ID: 33858449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Mitochondrial-Related Gene Signature for the Tumor Immune Microenvironment Evaluation and Prognosis Prediction in Lung Adenocarcinoma.
    Li YP; Liu GX; Wu ZL; Tu PH; Wei G; Yuan M; Zhong MH; Deng KL
    J Immunol Res; 2022; 2022():5366185. PubMed ID: 35664356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel M6A-Related Genes Signature Can Impact the Immune Status and Predict the Prognosis and Drug Sensitivity of Lung Adenocarcinoma.
    Wang X; Zhao C; Huang D; Liu Z; Liu M; Lin F; Lu Y; Jia J; Lin L; Lin X; Li H; Chen Z
    Front Immunol; 2022; 13():923533. PubMed ID: 35860262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma.
    Li Y; Shen R; Wang A; Zhao J; Zhou J; Zhang W; Zhang R; Zhu J; Liu Z; Huang JA
    Front Cell Dev Biol; 2021; 9():648806. PubMed ID: 33869203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Risk Signature and Comprehensive Analyses of Endoplasmic Reticulum Stress-Related Genes in Lung Adenocarcinoma.
    Yang C; Wei Y; Li W; Wei J; Chen G; Xu M; Liu G
    J Immunol Res; 2022; 2022():6567916. PubMed ID: 35571564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a three-gene expression signature and construction of a prognostic nomogram predicting overall survival in lung adenocarcinoma based on TCGA and GEO databases.
    Zhou Y; Gao S; Yang R; Du C; Wang Y; Wu Y
    Transl Lung Cancer Res; 2022 Jul; 11(7):1479-1496. PubMed ID: 35958325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Immune-Related Gene Signature Predicts Prognosis of Lung Adenocarcinoma.
    Ma C; Li F; Wang Z; Luo H
    Biomed Res Int; 2022; 2022():4995874. PubMed ID: 35437508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
    Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
    Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.